Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 4814696, 10 pages
https://doi.org/10.1155/2018/4814696
Research Article

Role of miR-200c in Myogenic Differentiation Impairment via p66Shc: Implication in Skeletal Muscle Regeneration of Dystrophic mdx Mice

1Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy
2Department of Biology and Biotechnology “Charles Darwin”, Sapienza University of Rome, Roma, Italy
3Institute of Cell Biology and Neurobiology (IBCN), Italian National Research Council (CNR), 00143 Rome, Italy
4Fondazione Santa Lucia IRCCS, 00143 Rome, Italy
5Vascular Pathology Laboratory, Instituto Dermopatico dell’Immacolata-IRCCS, FLMM, Via dei Monti di Creta 104, 00167 Rome, Italy
6Department of Cardiology, Ochsner Medical Center, 1514 Jefferson Hwy., New Orleans, LA 70121, USA

Correspondence should be addressed to Alessandra Magenta; moc.liamg@atnegam.ela

Received 31 July 2017; Revised 18 December 2017; Accepted 25 December 2017; Published 13 February 2018

Academic Editor: Andrey J. Serra

Copyright © 2018 Marco D’Agostino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Zaccagnini, F. Martelli, A. Magenta et al., “p66ShcA and oxidative stress modulate myogenic differentiation and skeletal muscle regeneration after hind limb ischemia,” The Journal of Biological Chemistry, vol. 282, no. 43, pp. 31453–31459, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Zaccagnini, F. Martelli, P. Fasanaro et al., “p66ShcA modulates tissue response to hindlimb ischemia,” Circulation, vol. 109, no. 23, pp. 2917–2923, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Bonfini, E. Migliaccio, G. Pelicci, L. Lanfrancone, and P. G. Pelicci, “Not all Shc’s roads lead to Ras,” Trends in Biochemical Sciences, vol. 21, no. 7, pp. 257–261, 1996. View at Publisher · View at Google Scholar
  4. A. Magenta, S. Greco, M. C. Capogrossi, C. Gaetano, and F. Martelli, “Nitric oxide, oxidative stress, and p66Shc interplay in diabetic endothelial dysfunction,” BioMed Research International, vol. 2014, Article ID 193095, 16 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Magenta, S. Greco, C. Gaetano, and F. Martelli, “Oxidative stress and microRNAs in vascular diseases,” International Journal of Molecular Sciences, vol. 14, no. 9, pp. 17319–17346, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. R. M. O’Connell, D. S. Rao, and D. Baltimore, “MicroRNA regulation of inflammatory responses,” Annual Review of Immunology, vol. 30, no. 1, pp. 295–312, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Horak, J. Novak, and J. Bienertova-Vasku, “Muscle-specific microRNAs in skeletal muscle development,” Developmental Biology, vol. 410, no. 1, pp. 1–13, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Magenta, C. Cencioni, P. Fasanaro et al., “miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition,” Cell Death and Differentiation, vol. 18, no. 10, pp. 1628–1639, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Carlomosti, M. D’Agostino, S. Beji et al., “Oxidative stress-induced miR-200c disrupts the regulatory loop among SIRT1, FOXO1 and eNOS,” Antioxidants & Redox Signaling, vol. 27, no. 6, pp. 328–344, 2016. View at Publisher · View at Google Scholar
  11. J. R. Terrill, H. G. Radley-Crabb, T. Iwasaki, F. A. Lemckert, P. G. Arthur, and M. D. Grounds, “Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies,” The FEBS Journal, vol. 280, no. 17, pp. 4149–4164, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Petrillo, L. Pelosi, F. Piemonte et al., “Oxidative stress in Duchenne muscular dystrophy: focus on the NRF2 redox pathway,” Human Molecular Genetics, vol. 26, no. 14, pp. 2781–2790, 2017. View at Publisher · View at Google Scholar
  13. S. Greco, M. De Simone, C. Colussi et al., “Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia,” The FASEB Journal, vol. 23, no. 10, pp. 3335–3346, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Dalkilic and L. M. Kunkel, “Muscular dystrophies: genes to pathogenesis,” Current Opinion in Genetics & Development, vol. 13, no. 3, pp. 231–238, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. N. P. Evans, S. A. Misyak, J. L. Robertson, J. Bassaganya-Riera, and R. W. Grange, “Dysregulated intracellular signaling and inflammatory gene expression during initial disease onset in Duchenne muscular dystrophy,” American Journal of Physical Medicine & Rehabilitation, vol. 88, no. 6, pp. 502–522, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Pichavant, A. Aartsma-Rus, P. R. Clemens et al., “Current status of pharmaceutical and genetic therapeutic approaches to treat DMD,” Molecular Therapy, vol. 19, no. 5, pp. 830–840, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Sicinski, Y. Geng, A. S. Ryder-Cook, E. A. Barnard, M. G. Darlison, and P. J. Barnard, “The molecular basis of muscular dystrophy in the mdx mouse: a point mutation,” Science, vol. 244, no. 4912, pp. 1578–1580, 1989. View at Publisher · View at Google Scholar
  18. A. Sacco, F. Mourkioti, R. Tran et al., “Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice,” Cell, vol. 143, no. 7, pp. 1059–1071, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. C. J. Mann, E. Perdiguero, Y. Kharraz et al., “Aberrant repair and fibrosis development in skeletal muscle,” Skeletal Muscle, vol. 1, no. 1, p. 21, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. N. A. Dumont, Y. X. Wang, J. von Maltzahn et al., “Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division,” Nature Medicine, vol. 21, no. 12, pp. 1455–1463, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Biressi, E. H. Miyabara, S. D. Gopinath, P. M. M. Carlig, and T. A. Rando, “A Wnt-TGFβ2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice,” Science Translational Medicine, vol. 6, no. 267, article 267ra176, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Pessina, Y. Kharraz, M. Jardí et al., “Fibrogenic cell plasticity blunts tissue regeneration and aggravates muscular dystrophy,” Stem Cell Reports, vol. 4, no. 6, pp. 1046–1060, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Follenzi and L. Naldini, “HIV-based vectors. Preparation and use,” Gene Therapy Protocols, vol. 69, pp. 259–274, 2002. View at Google Scholar
  24. C. G. Crist, D. Montarras, and M. Buckingham, “Muscle satellite cells are primed for myogenesis but maintain quiescence with sequestration of Myf5 mRNA targeted by microRNA-31 in mRNP granules,” Cell Stem Cell, vol. 11, no. 1, pp. 118–126, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Saccone, S. Consalvi, L. Giordani et al., “HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles,” Genes & Development, vol. 28, no. 8, pp. 841–857, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Magenta, P. Fasanaro, S. Romani, V. Di Stefano, M. C. Capogrossi, and F. Martelli, “Protein phosphatase 2A subunit PR70 interacts with pRb and mediates its dephosphorylation,” Molecular and Cellular Biology, vol. 28, no. 2, pp. 873–882, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Ardite, J. A. Barbera, J. Roca, and J. C. Fernández-Checa, “Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-κB activation,” The American Journal of Pathology, vol. 165, no. 3, pp. 719–728, 2004. View at Publisher · View at Google Scholar
  28. S. Fulle, F. Protasi, G. Di Tano et al., “The contribution of reactive oxygen species to sarcopenia and muscle ageing,” Experimental Gerontology, vol. 39, no. 1, pp. 17–24, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. J. M. Hansen, M. Klass, C. Harris, and M. Csete, “A reducing redox environment promotes C2C12 myogenesis: implications for regeneration in aged muscle,” Cell Biology International, vol. 31, no. 6, pp. 546–553, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Vignier, F. Amor, P. Fogel et al., “Distinctive serum miRNA profile in mouse models of striated muscular pathologies,” PLoS One, vol. 8, no. 2, article e55281, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. J. E. Anderson, “A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells,” Molecular Biology of the Cell, vol. 11, no. 5, pp. 1859–1874, 2000. View at Publisher · View at Google Scholar
  32. K. H. Lee, D. G. Kim, N. Y. Shin et al., “NF-κB-dependent expression of nitric oxide synthase is required for membrane fusion of chick embryonic myoblasts,” Biochemical Journal, vol. 324, Part 1, no. 1, pp. 237–242, 1997. View at Publisher · View at Google Scholar
  33. N. R. Madamanchi and M. S. Runge, “Mitochondrial dysfunction in atherosclerosis,” Circulation Research, vol. 100, no. 4, pp. 460–473, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Francia, C. delli Gatti, M. Bachschmid et al., “Deletion of p66Shc gene protects against age-related endothelial dysfunction,” Circulation, vol. 110, no. 18, pp. 2889–2895, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Kasai, K. Abeyama, T. Hashiguchi, H. Fukunaga, M. Osame, and I. Maruyama, “Decreased total nitric oxide production in patients with Duchenne muscular dystrophy,” Journal of Biomedical Science, vol. 11, no. 4, pp. 534–537, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Kuno and Y. Horio, “SIRT1: a novel target for the treatment of muscular dystrophies,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 6714686, 11 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Chalkiadaki, M. Igarashi, A. S. Nasamu, J. Knezevic, and L. Guarente, “Muscle-specific SIRT1 gain-of-function increases slow-twitch fibers and ameliorates pathophysiology in a mouse model of Duchenne muscular dystrophy,” PLoS Genetics, vol. 10, no. 7, article e1004490, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Potente and S. Dimmeler, “Emerging roles of SIRT1 in vascular endothelial homeostasis,” Cell Cycle, vol. 7, no. 14, pp. 2117–2122, 2008. View at Publisher · View at Google Scholar